Related Experiment Video
Updated: Dec 18, 2025

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
Tonsillar immunology in IgA nephropathy
Xinxin Yang1, Anchao Zhu1, Hongxue Meng1
1Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China.
IgA nephropathy (IgAN) involves IgA1 in the kidneys. This review explores new treatments and prevention strategies for IgAN, focusing on the gut immune system and related factors for better patient therapy.
Area of Science:
- Immunology
- Nephrology
- Gastroenterology
Background:
- IgA nephropathy (IgAN) is a common glomerulonephritis marked by IgA1 deposition in the kidney's mesangial area.
- Current treatments include tonsillectomy and conservative approaches, informed by the role of the mucosa immune system (MIS), particularly mucosa-associated lymphoid tissue (MALT).
- Basic research links IgAN to serum Gd-IgA1, IgA-IgG immune complexes, tonsil bacteria, and genetic factors like GADD34, CX3CR1, and FOXP3.
Purpose of the Study:
- To review recent advancements in the treatment and prevention of IgA nephropathy.
- To explore the underlying mechanisms of IgAN, with a specific focus on the role of tonsils and the mucosa immune system.
- To highlight the potential interconnections among various IgAN-associated factors.
Main Methods:
- Literature review of recent studies on IgA nephropathy.
- Analysis of immunological and genetic factors implicated in IgAN pathogenesis.
- Examination of clinical treatment strategies and their immunological basis.
Main Results:
- The review synthesizes current knowledge on IgAN, emphasizing the interplay between systemic and mucosal immunity.
- Identified key factors such as serum Gd-IgA1, genetic predispositions, and microbial triggers.
- Highlighted the significance of tonsil-associated immunity in IgAN development and potential therapeutic targets.
Conclusions:
- Understanding the complex interplay of factors in IgAN is crucial for developing effective therapies.
- Targeting the mucosa immune system and related pathways offers promising avenues for IgAN treatment and prevention.
- Further research into the mutual correlations among IgAN-associated factors will significantly benefit patient outcomes.
Related Concept Videos
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Acute Kidney Injury II: Pathophysiology
Nephrotic Syndrome I : Introduction
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Humoral Immune Responses

